|Articles|February 1, 2000

Ace Inhibitors and Their Utilization in Managed Care
Volume 6
Issue 3 Suppl

Care 8: Post-Myocardial Infarction; Asymptomatic Left Ventricular Dysfunction

Download PDF: Care 8: Post-Myocardial Infarction; Asymptomatic Left Ventricular Dysfunction

Articles in this issue

about 26 years ago

Article

Participating Faculty

about 26 years ago

Article

Continuing Medical and Pharmacy Educational Objectives

about 26 years ago

Article

Glossary of Abbreviations

about 26 years ago

Article

Class Effects of Angiotensin-Converting Enzyme Inhibitors (Quiz)

about 26 years ago

Article

The Impact of Angiotensin-Converting Enzyme Inhibitors on Managed Care: Economic, Clinical, and Humanistic Outcomes (Quiz)

about 26 years ago

Article

Case 1: Hypertension; Impaired Glucose Tolerance (Quiz)

about 26 years ago

Article

Case 2: Hypertension Therapy in Managed Care (Quiz)

about 26 years ago

Article

Case 3: Coronary Heart Disease; Hypertension

about 26 years ago

Article

Case 4: Systolic Hypertension; Diabetes Mellitus; Renal Dysfunction; and the Use of ACE Inhibitors in African-American Population

about 26 years ago

Article

Case 5: Congestive Heart Failure; Prior Myocardial Infarction; Economic Consideration of Care in Medicare Population

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Care 8: Post-Myocardial Infarction; Asymptomatic Left Ventricular Dysfunction

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention